本页面由Tiger Trade Technology Pte. Ltd.提供服务

REIN THERAPEUTICS INC

0.3369
-0.0308-8.38%
盘后:0.39000.0531+15.76%19:30 EST
成交量:66.87万
成交额:23.90万
市值:2,881.81万
市盈率:-0.21
高:0.3899
开:0.3575
低:0.3352
收:0.3677
52周最高:2.10
52周最低:0.2844
股本:8,553.90万
流通股本:6,583.01万
量比:0.24
换手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-1.5693
每股收益(LYR):-1.9600
净资产收益率:-100.48%
总资产收益率:-24.60%
市净率:3.71
市盈率(LYR):-0.17

数据加载中...

2026/11/16

重要事件披露

Form 8-K - Current report
2026/11/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/09/04

重要事件披露

Form 8-K - Current report
2026/08/28

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

重要事件披露

Form 8-K - Current report
2026/07/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/28

SEC问询函

Form CORRESP - Correspondence
2026/04/28

SEC问询函

Form CORRESP - Correspondence
2026/04/28

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/27

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]